Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
The Annals of Pharmacotherapy|June 3, 2018
Smoking Cessation Following Text Message Intervention in Pregnant WomenAlicia B Forinash, Abigail Yancey, Danielle Chamness, et al.
Health Physics|February 24, 2001
An overview of EPA regulation of the safe disposal of transuranic waste at the Waste Isolation Pilot PlantA B Wolbarst, E K Forinash, C O Byrum, et al.
American Journal of Obstetrics and Gynecology|May 27, 2015
Should pregnant women be included in phase IV clinical drug trials?Gerald G Briggs, Janine E Polifka, Katherine L Wisner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2011
Combination of farnesyltransferase and Akt inhibitors is synergistic in breast cancer cells and causes significant breast tumor regression in ErbB2 transgenic miceMaria E Balasis, Kara D Forinash, Y Ann Chen, et al.
Cancer Research|August 1, 2012
RKI-1447 is a potent inhibitor of the Rho-associated ROCK kinases with anti-invasive and antitumor activities in breast cancerRonil A Patel, Kara D Forinash, Roberta Pireddu, et al.
The Annals of Pharmacotherapy|February 6, 2018
Administration Rates of the Tdap Vaccine in Obstetric PatientsJamie Koerner, Alicia B Forinash, Abigail M Yancey, et al.
The Annals of Pharmacotherapy|February 3, 2012
Obstetrical opportunities: will pharmacy ever realize them?Denise Ragland, Gerald G Briggs, Mitzi Wasik, et al.
Medchemcomm|January 1, 2013
Pyridylthiazole-based ureas as inhibitors of Rho associated protein kinases (ROCK1 and 2)Roberta Pireddu, Kara D Forinash, Nan N Sun, et al.
The Annals of Pharmacotherapy|March 10, 2018
Guide for Drug Selection During Pregnancy and Lactation: What Pharmacists Need to Know for Current PracticeBrooke L Griffin, Rebecca H Stone, Shareen Y El-Ibiary, et al.
Pageof 4